Mind Medicine Return On Equity vs. EBITDA
| MNMD Stock | USD 7.09 0.43 5.72% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter (1.23) | Current Value (1.29) | Quarterly Volatility 0.40098304 |
For Mind Medicine profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Mind Medicine to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Mind Medicine utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Mind Medicine's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Mind Medicine over time as well as its relative position and ranking within its peers.
Mind |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mind Medicine. If investors know Mind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.71) | Return On Assets (0.25) | Return On Equity (0.55) |
The market value of Mind Medicine is measured differently than its book value, which is the value of Mind that is recorded on the company's balance sheet. Investors also form their own opinion of Mind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Mind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mind Medicine's market value can be influenced by many factors that don't directly affect Mind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Mind Medicine EBITDA vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Mind Medicine's current stock value. Our valuation model uses many indicators to compare Mind Medicine value to that of its competitors to determine the firm's financial worth. Mind Medicine is rated below average in return on equity category among its peers. It is rated below average in ebitda category among its peers . At present, Mind Medicine's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Mind Medicine by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Mind EBITDA vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Mind Medicine |
| = | -0.55 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Mind Medicine |
| = | (92.57 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Mind EBITDA Comparison
Mind Medicine is currently under evaluation in ebitda category among its peers.
Mind Medicine Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Mind Medicine, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Mind Medicine will eventually generate negative long term returns. The profitability progress is the general direction of Mind Medicine's change in net profit over the period of time. It can combine multiple indicators of Mind Medicine, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 343 K | 513.6 K | |
| Interest Income | 839.5 K | 881.5 K | |
| Operating Income | -93.9 M | -89.2 M | |
| Income Before Tax | -95.7 M | -90.9 M | |
| Net Loss | -51.1 M | -53.7 M | |
| Net Loss | -95.7 M | -90.9 M | |
| Total Other Income Expense Net | -1.9 M | -1.8 M | |
| Income Tax Expense | -8.6 M | -8.2 M | |
| Net Interest Income | 4.8 M | 5.1 M | |
| Net Loss | -76.8 M | -80.6 M | |
| Non Operating Income Net Other | 11 M | 11.5 M | |
| Change To Netincome | 6.6 M | 6.2 M | |
| Net Loss | (2.44) | (2.57) | |
| Income Quality | 0.67 | 0.44 | |
| Net Income Per E B T | 0.96 | 1.03 |
Mind Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Mind Medicine. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Mind Medicine position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Mind Medicine's important profitability drivers and their relationship over time.
Use Mind Medicine in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mind Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mind Medicine will appreciate offsetting losses from the drop in the long position's value.Mind Medicine Pair Trading
Mind Medicine Pair Trading Analysis
The ability to find closely correlated positions to Mind Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mind Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mind Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mind Medicine to buy it.
The correlation of Mind Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mind Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mind Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mind Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Mind Medicine position
In addition to having Mind Medicine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Blend Funds Thematic Idea Now
Small Blend Funds
Fund or Etfs that invest in stocks of small to mid-sized entities that have characteristics of both growth and value companies. The Small Blend Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
To fully project Mind Medicine's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Mind Medicine at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Mind Medicine's income statement, its balance sheet, and the statement of cash flows.